Phio Pharmaceuticals
PHIO
#10279
Rank
โ‚น1.13 B
Marketcap
โ‚น102.73
Share price
-2.56%
Change (1 day)
-56.92%
Change (1 year)

Revenue for Phio Pharmaceuticals (PHIO)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Phio Pharmaceuticals from 2011 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 โ‚น1.49 M-84.48%
2018 โ‚น9.64 M907.48%
2017 โ‚น0.95 M-25.82%
2016 โ‚น1.29 M-42.86%
2015 โ‚น2.25 M-49.79%
2014 โ‚น4.49 M-81.75%
2013 โ‚น24.65 M364.13%
2012 โ‚น5.31 M
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.36 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.86 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA